3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Cancer, Papillary
1
Precancerous Conditions
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Gliosarcoma
1
Glioblastoma
1
Cervical Neoplasia
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Surgical Procedures, Operative
2
Radiotherapy
2
Lymph Node Excision
2
lncRNA LNMAT1, human
1
gewf solution
1
gadofosveset trisodium
1
fluoroazomycin arabinoside
1
Thyroidectomy
1
Technetium
1
Surgery, Computer-Assisted
1
Spectrum Analysis
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Methylene Blue
1
Metformin
1
Leuprolide
1
Indocyanine Green
1
Goserelin
1
Esophagectomy
1
Electroporation
1
Docetaxel
1
Cytoreduction Surgical Procedures
1
Congresses as Topic
1
Axitinib
1
Artificial Intelligence
1
Androgen Antagonists
1
Acceleration
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphatic Metastasis
×
Spectrum Analysis
×
Clear all
NCT03470259
2024-04-16
TARGET
University Medical Center Groningen
Phase 1
Completed
19 enrolled